| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/03/2003 | WO2003053940A1 Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053930A1 1,4-dihydro-1,4-diphenylpyridine derivatives |
| 07/03/2003 | WO2003053928A1 Serotonine reuptake inhibitor |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053922A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | WO2003053431A2 Pharmaceutical compositions based on azetidine derivatives |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053344A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2002101073A3 Aryl-benzimidazole compounds having antiinfective activity |
| 07/03/2003 | WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates |
| 07/03/2003 | WO2002062295A3 Pyridine-substituted benzanilides as potassium ion channel openers |
| 07/03/2003 | US20030125555 Piperidine-N-oxy group containing compounds stabilizes white, dyed, dipped, unscented or scented candle wax against discolration and fading |
| 07/03/2003 | US20030125550 1-aryl or heteroaryl substituted benzimidazole derivatives useful for treatment of diseases that are associated with microglia activation, such as inflammatory, allergic infectious or autoimmune diseases |
| 07/03/2003 | US20030125370 Treating or preventing protein kinase related disorders in a organism, such as cancer, diabetes, autoimmune disoders, hyperproliferation diosrders, osteoarthritis, rhematoid arthritis, angiogenesis, immunological disorders |
| 07/03/2003 | US20030125369 New indenoindolone compounds |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125317 Vitronectin receptor antagonists |
| 07/03/2003 | US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 07/03/2003 | US20030124053 Radiopharmaceuticals for imaging infection and inflammation |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | CA2471355A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | CA2471079A1 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 07/03/2003 | CA2470813A1 1,4-dihydro-1,4-diphenylpyridine derivatives |
| 07/03/2003 | CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 07/03/2003 | CA2470443A1 Pharmaceutical compositions based on azetidine derivatives |
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 07/02/2003 | EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 07/02/2003 | EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa |
| 07/02/2003 | EP1322637A2 Quaternary amidino based inhibitors of factor xa |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 07/02/2003 | EP1322634A1 N-phenyl-2-pyrimidine-amine derivatives |
| 07/02/2003 | EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 07/02/2003 | EP1322625A2 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 07/02/2003 | EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 07/02/2003 | EP1322608A1 Delta1-pyrrolines used as pesticides |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322596A1 Zwitterionic tachykinin receptor antagonists |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1124539B1 Pharmaceutical formulation comprising omeprazole |
| 07/02/2003 | EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 07/02/2003 | EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | EP0913392B1 Ethylene derivatives and pest controlling agents |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |
| 07/02/2003 | CN1427838A Hydantoin-containing glucokinase activators |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427836A Method for obtaining derivatives of [[(pyridil substituted) methyl] thio] benzimidazol |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427824A Indole derivatives, process for preparation of same and use thereof |
| 07/02/2003 | CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 07/02/2003 | CN1427816A Process for forming amide bond |
| 07/02/2003 | CN1113064C Cis-substituted aminocyclopropane derivatives |
| 07/02/2003 | CN1113063C Heterocyclyluracil |
| 07/02/2003 | CN1113060C Substituted 2-amino-4-alkylamino-1,3,5-triazine as herbicide |
| 07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
| 07/02/2003 | CN1112923C Indazole carboxamides |
| 07/02/2003 | CN1112848C Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component |
| 07/01/2003 | US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 07/01/2003 | US6586604 Tricyclic amine derivatives |
| 07/01/2003 | US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction |
| 07/01/2003 | US6586466 Carbohydrazide-protease inhibitors |
| 07/01/2003 | US6586447 Farnesyl protein transferase inhibitors such as 4-(6-(4-Cyano -phenyl)-3,3-bis-(1H-imidazol-4-ylmethyl)-2-oxo-2,3- dihydro-indol-1-ylmethyl)-N,N-dimethyl benzenesulfonamide used as anticarcinogenic agents |
| 07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
| 07/01/2003 | US6586439 Pharmaceutically active compounds |
| 07/01/2003 | US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/01/2003 | US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders |
| 07/01/2003 | US6586420 Photostable bactericides |
| 07/01/2003 | US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders |